Myocardial T1 mapping: where are we now and where are we going?

Cardiovascular magnetic resonance offers noninvasive myocardial tissue characterization as a key unique strength over other imaging techniques. In particular T1, a tissue property that alters with disease, has gained prominence as a diagnostic tool. Prior to the admin- istration of contrast, the native T1 changes with a number of processes such as fibrosis, edema, and infiltration. If a post-contrast scan is also acquired, the post-contrast T1 and extracellular volume fraction can be measured. Detecting and quantifying early and established myocardial pathological processes permits better diagnosis, prognostication, and tracking of therapy.

[1]  C. Wanner,et al.  Fabry disease and the heart. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[2]  U. Sechtem,et al.  Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. , 2014, European heart journal cardiovascular Imaging.

[3]  Andrew J Taylor,et al.  Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. , 2014, Heart rhythm.

[4]  J. Townend,et al.  Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. , 2014, JACC. Cardiovascular imaging.

[5]  Richard B Thompson,et al.  Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping , 2014, Magnetic resonance in medicine.

[6]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[7]  Richard B. Thompson,et al.  Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. , 2014, Radiology.

[8]  L. Kuller,et al.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. , 2014, European heart journal.

[9]  D. Stub,et al.  Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. , 2014, Journal of the American College of Cardiology.

[10]  S. K. White,et al.  Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[11]  L. Brunereau,et al.  Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience , 2014, Journal of Cardiovascular Magnetic Resonance.

[12]  J. Moon,et al.  Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study , 2014, Journal of Cardiovascular Magnetic Resonance.

[13]  J. Moon,et al.  Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues , 2014, Current Cardiovascular Imaging Reports.

[14]  P. Kellman,et al.  T1-mapping in the heart: accuracy and precision , 2014, Journal of Cardiovascular Magnetic Resonance.

[15]  B. Prendergast,et al.  Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations , 2013, BMJ Open.

[16]  G. Maurer,et al.  Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.

[17]  C. Jellis,et al.  Myocardial T1 mapping: modalities and clinical applications. , 2013, Cardiovascular diagnosis and therapy.

[18]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[19]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[20]  Tobias Schaeffter,et al.  Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.

[21]  M. Friedrich,et al.  Cardiac Magnetic Resonance Assessment of Myocarditis , 2013, Circulation. Cardiovascular imaging.

[22]  Stefan L. Zimmerman,et al.  Cardiac magnetic resonance T1 mapping of left atrial myocardium. , 2013, Heart rhythm.

[23]  Sung Ho Hwang,et al.  Diagnosis of Acute Global Myocarditis Using Cardiac MRI with Quantitative T1 and T2 Mapping: Case Report and Literature Review , 2013, Korean journal of radiology.

[24]  L. Ling,et al.  Diffuse Ventricular Fibrosis Is a Late Outcome of Tachycardia-Mediated Cardiomyopathy After Successful Ablation , 2013, Circulation. Arrhythmia and electrophysiology.

[25]  D. Bluemke,et al.  Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners , 2013, Journal of Cardiovascular Magnetic Resonance.

[26]  Harry Rakowski,et al.  Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. , 2013, JACC. Cardiovascular imaging.

[27]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[28]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[29]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[30]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[31]  S. K. White,et al.  Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease , 2013, Journal of Cardiovascular Magnetic Resonance.

[32]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[33]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[34]  A. Flett,et al.  Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.

[35]  L. Ling,et al.  Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.

[36]  M. Dweck,et al.  Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.

[37]  A. Taylor,et al.  Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.

[38]  G. Faggian,et al.  Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. , 2012, The Journal of thoracic and cardiovascular surgery.

[39]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[40]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[41]  Steffen Ringgaard,et al.  Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[42]  E. Cassinerio,et al.  An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.

[43]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[44]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[45]  S. Plein,et al.  Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.

[46]  W. Kim,et al.  Mass Reduction and Functional Improvement of the Left Ventricle after Aortic Valve Replacement for Degenerative Aortic Stenosis , 2011, The Korean journal of thoracic and cardiovascular surgery.

[47]  C. Kramer,et al.  Cardiovascular Magnetic Resonance Applications in Daily Practice , 2011 .

[48]  O. Simonetti,et al.  Direct T2 quantification of myocardial edema in acute ischemic injury. , 2011, JACC. Cardiovascular imaging.

[49]  Pierre Croisille,et al.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.

[50]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[51]  M. Beer,et al.  Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.

[52]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[53]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[54]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[55]  Katherine C. Wu,et al.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[56]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[57]  Andreas Greiser,et al.  Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.

[58]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[59]  S. Neubauer,et al.  Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. , 2006, International journal of cardiology.

[60]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[61]  David M Higgins,et al.  Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. , 2006, Radiology.

[62]  L. Brown Cardiac extracellular matrix: a dynamic entity. , 2005, American journal of physiology. Heart and circulatory physiology.

[63]  R. Falk,et al.  Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.

[64]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[65]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[66]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[67]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[68]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[69]  S. Neubauer,et al.  The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies , 2012, Current Cardiology Reports.

[70]  P. Elliott,et al.  Anderson-Fabry disease and the heart. , 2010, Progress in cardiovascular diseases.

[71]  O. Vignaux Cardiac sarcoidosis: spectrum of MRI features. , 2005, AJR. American journal of roentgenology.